We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Innovative Catheter Guidance Technology Aims for Zero Malpositioning

By HospiMedica International staff writers
Posted on 17 Sep 2024
Print article
Image: The PM2 System with ECGuide Connector (Photo courtesy of Piccolo Medical)
Image: The PM2 System with ECGuide Connector (Photo courtesy of Piccolo Medical)

Millions of catheters are still being inserted each year without the use of guidance, posing unnecessary risks to patients. Blind insertions require confirmation through chest X-ray, which increases hospital costs, exposes patients to more radiation, and delays the start of medication infusion. Now, a new catheter guidance technology that utilizes intravascular cardiac electrical activity (ECG) offers an alternative method for confirming proper catheter placement, eliminating the need for chest X-rays.

Piccolo Medical (San Francisco, CA, USA) has developed the ECGuide technology, which uses the patient's ECG to determine the catheter tip position in real time. It has been approved as a substitute for chest X-rays to confirm correct catheter placement. While catheter guidance systems are commonly used in Peripherally Inserted Central Catheter (PICC) procedures, their adoption for Central Venous Catheter (CVC) procedures in the U.S. has been limited. Studies have shown that intravascular ECG technology enhances accuracy in both CVC and PICC placements and reduces complication rates.

Piccolo has now received clearance from the U.S. Food and Drug Administration (FDA) to market its PM2 System with ECGuide Connector, an innovative catheter guidance technology. This addition to Piccolo's product portfolio is aimed at reducing complications associated with central venous catheter insertions, a procedure that impacts over 8 million patients annually.

"Millions of catheters are still being inserted without guidance every year," said Augustus Shanahan, CEO of Piccolo Medical. "The evidence is clear: blind insertions pose unnecessary risks to patients and incur additional costs for hospitals. With the launch of ECGuide, we aim to overcome barriers related to cost and complexity, ultimately driving the industry towards a goal of zero malpositioning."

Related Links:
Piccolo Medical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Oxygen Concentrator
Nuvo 10
New
Tabletop Steam Autoclave
T24

Print article

Channels

Critical Care

view channel
Image: The Biointegrated Implantable Systems for Cell-based Sensing and Therapy technology can be used to treat various diseases (Photo courtesy of 123RF)

Implantable Cell-Based Bioelectronic Devices to Enable Patient-Specific Treatment and Disease Monitoring

Researchers are advancing the development of implantable, cell-based bioelectronic devices designed to provide personalized therapy and monitor disease conditions such as hypo- and hyperthyroidism in real-time.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.